Dacomitinib is an EGFR inhibitor designed for people with Non-Small Cell Lung Cancer (NSCLC), mainly for those who have specific EGFR mutations, like exon 19 deletion or L858R mutation. It stops the EGFR pathway from doing its thing. You can get it in three strengths—15, 30, or 45 mg—and it comes as film-coated pills.
Doctors usually suggest taking the 45 mg version, and you do that just once a day. Each pack comes in a bottle with 30 tablets inside.
Reviews
There are no reviews yet.